Riesgo cardiovascular en pacientes con VIH

摘要: Background: Antiretroviral therapy in HIV patients has caused lipid and glucose metabolism alterations. Objective: To compare prevalence of cardiovascular risk at 10 years over 10%, a group HIV-infected with HAART, another without HAART. Patients methods: A clinical-epidemiological, multicentre comparative study was performed. Lipid profile criteria were determined according ATP-III. Cardiovascular calculated trough Framingham equation. 10% considered high risk. When p value lower than 0.05, it statistically significant between both groups. Results: 256 adults patient studied, 207 receiving HAART (group 1) 49 2). Prevalence above 16% 1, 12% 2. Average equation higher 1 (6.6 ± 5.6% vs 5.2 5.0%, = 0.02). Variables meaningful for were: smoking, age, male gender non-HDL cholesterol. Conclusions: similar Nevertheless, average 1. Risk factors subjects 45 old could be useful tool that will require more extensive studies to validate this population group.